Sanders Calls for Support of California Drug Pricing Initiative
A California initiative to require drug makers to provide large discounts to state agencies has received revived news…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Senate Aging Committee Finally Hears from Valeant
Recently, the Senate Special Committee on Aging held a two-panel hearing on "Valeant Pharmaceuticals' Business Model: the…
E&C Subcommittee Hearing, HHS OIG and GAO Reports on Medicare and…
On May 24, 2016, the House Energy and Commerce Subcommittee on Oversight and Investigations held a hearing entitled, "Medicare and…
CMS Administrator Goes to Twitter to Explain the Proposed Rule for the…
In an very unusual move for a government regulator, the CMS acting administrator Andy Slavitt took to Twitter to explain his…
New Report: Industry and Physician Interaction Considered Acceptable by…
In this contentious election year, favorable coverage of the pharmaceutical industry is, for some reason, hard to come…
NIH Asks for Input on NCAB Cancer Moonshot Blue Ribbon Panel
Recently, the National Institutes of Health (NIH) released a Request for Information (RFI), asking for both public and…
Understanding the CMS Proposed Rule for the Medicare Access and CHIP…
After reviewing the Merit-based Payment System (MIPS) in detail, we now focus our attention on the alternative payment…
Veterans Affairs Committee Hearing on VA-Established CME
On Tuesday, May 24, 2016, the United States Senate Committee on Veterans' Affairs held a hearing on pending legislation…
Understanding the CMS Proposed Rule for the Medicare Access and CHIP…
As we have reported, the Centers for Medicare and Medicaid Services (CMS) released its proposed rule to implement the…
CMS 2014 Medicare Part D Data Release and One CMS Officials Interpretation
For the third year now The Centers for Medicare and Medicaid Services (CMS) released its updated Physician and Other Supplier…